Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...

MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...

Post-traumatic stress disorder comes in many forms and affects each person differently. Some patients benefit more from residential, in-treatment programs, while others are more suited for outpatient ...

Lipodermatosclerosis is rare in those with systemic sclerosis but is associated with a higher rate of complications, including pulmonary hypertension.

The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Many outpatients with moderate to severe COPD had suboptimal peak inspiratory flow and had inappropriate devices for measured PIF.

Male sex was also shown to be an independent risk factor for longer hospital stays and increased hospitalization costs at ...

Explore how health-related quality of life influences re-hospitalization and mortality risk in COPD patients admitted with ...

The wearable device can track a COPD patient’s personal exposure to pollutants and respiratory triggers, assess their lung ...

November is COPD Awareness Month. Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death in the U.S. behind ...

For individuals with Chronic Obstructive Pulmonary Disease (COPD), exercise plays an important role. Here are some exercises ...